FSLR
47
7
AA
41
3
MUR
48
3
EXC
53
12
AIZ
80
2
NSC
57
-7
APA
25
5
ZION
67
-4
PCG
94
-5
TEL
69
-5
XRX
37
3
OXY
52
-3
MLM
51
-6
KHC
15
-2
CSCO
61
-6
GIS
26
-3
IRM
39
-3
DAL
88
-2
FLR
50
2
TGNA
56
-3
FSLR
47
7
AA
41
3
MUR
48
3
EXC
53
12
AIZ
80
2
NSC
57
-7
APA
25
5
ZION
67
-4
PCG
94
-5
TEL
69
-5
XRX
37
3
OXY
52
-3
MLM
51
-6
KHC
15
-2
CSCO
61
-6
GIS
26
-3
IRM
39
-3
DAL
88
-2
FLR
50
2
TGNA
56
-3
Financhill
Back

bluebird bio Vs. Perspective Therapeutics Industry Stock Comparison

Sell
21

BLUE
bluebird bio

Last Price:
0.36
Seasonality Move:
6.96%
Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Sell
21
bluebird bio (BLUE) is a Sell

Is bluebird bio a Buy, Sell or Hold?

  • The current bluebird bio [BLUE] share price is $0.36. The Score for BLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $8.92. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLUE Stock Price Chart

What is bluebird bio's stock price today?

  • The bluebird bio share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $8.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

BLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 26.9 Sell
Chaikin Money Flow: -1672517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.41 - 0.51) Sell
Bollinger Bands (100): (0.44 - 1) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 23.03 Sell
Chaikin Money Flow: -1324869 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.92 - 12.78) Sell
Bollinger Bands (100): (11.21 - 14.35) Sell

BLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.4 Sell
20-day SMA: 0.45 Sell
50-day SMA: 0.49 Sell
200-day SMA: 0.92 Sell
8-day EMA: 0.4 Sell
20-day EMA: 0.44 Sell
50-day EMA: 0.52 Sell
200-day EMA: 1.11 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.04 Sell
20-day SMA: 11.63 Sell
50-day SMA: 12.76 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.64 Sell
20-day EMA: 11.47 Sell
50-day EMA: 12.32 Sell
200-day EMA: 11.71 Sell

bluebird bio Earnings Growth & BLUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.46 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.25 per share.

bluebird bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):